Difference between revisions of "Isotretinoin (Accutane)"
Jump to navigation
Jump to search
m |
Warner-admin (talk | contribs) m (Text replacement - "[[Category:Drugs FDA" to "[[Category:FDA") |
||
| Line 19: | Line 19: | ||
[[Category:Squamous cell carcinoma (SCC) medications]] | [[Category:Squamous cell carcinoma (SCC) medications]] | ||
| − | [[Category: | + | [[Category:FDA approved in 1982]] |
Revision as of 19:09, 30 July 2018
Mechanism of action
From the NCI Drug Dictionary: A naturally-occurring retinoic acid with potential antineoplastic activity. Isotretinoin binds to and activates nuclear retinoic acid receptors (RARs); activated RARs serve as transcription factors that promote cell differentiation and apoptosis. This agent also exhibits immunomodulatory and anti-inflammatory responses and inhibits ornithine decarboxylase, thereby decreasing polyamine synthesis and keratinization.
Diseases for which it is used
Also known as
- Code name: Ro 4-3780
- Generic names: 13-cis-retinoic acid, 13-cis-vitamin A acid, cis-retinoic acid, isotretinoinum, neovitamin A
- Brand names: Accure, Accutane, Amnesteem, Cistane, Claravis, Isotrex, Isotrexin, Oratane, Roaccutan, Roaccutane, Roacutan, Sotret